chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rapid heart rate, dizzy lightheaded, headache, large rash at injection site f/u at Urgent Care steroid prescription
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 24-MAY-2017 the patient was vaccinated with ROTATEQ lot # M040268 for prophylaxis. On 24-MAY-2017, 1 day after onset of therapy the patient experienced incorrect product storage. On an unknown date the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to ROTATEQ. Sender's Comments: US-009507513-1708USA003628: US-009507513-1708USA003629: US-009507513-1708USA003635: US-009507513-1708USA003631: US-009507513-1708USA003632: US-009507513-1708USA003633: US-009507513-1708USA003634: US-009507513-1708USA003627: US-009507513-1708USA011937: US-009507513-1709USA001552: US-009507513-1708USA003630: US-009507513-1709USA001554.
I experienced minor heart palpitations right way after 2nd dose. It has gotten progressively worse; I'm under doctors care. Some days I have no palpitations but sometimes I wake up in the middle of the night with palpitations.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Dec2021 at 11:00 as dose 2 (booster), single (Lot number: Fh8027) at the age of 35 years, in left arm for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 03Apr2021 at 12:00 as dose 1, single (Lot number: 043A2IA), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: bees" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Acetaminophen, reaction(s): "Known allergies: Acetaminophen".  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid from 08Aug2022 to 09Aug2022).  Clinical course: Patient did not received other medication in 2 weeks. Anti viral details: Product: COVID 19 Treatment, Brand: Paxlovid, Treatment start date: 08Aug2022 and Treatment stop date: 09Aug2022, Lot number: NDC 0069-1085-30, for the Treatment of Covid-19. Patient having known allergies with Acetaminophen and bees.  No follow-up attempts are possible. No further information is expected.
10SEP98 devel fever 101 R;began giving APAP;11SEP98 fever 101.8R;12SEP98 103.4 3AM,T104.4 R 9AM;seen @ clinic;13SEP98 appearance of rash-red dots, behind ear, neck, back;14SEP98 rash inc to hairline;itchy;papular;15SEP98 papules broke open
This spontaneous report was received from a 84 year old female patient referring to herself. The patient's current conditions included codeine allergy and penicillin allergy. The patient's medical history included shingles. On unspecified date in October 2012 (reported as about two year ago) the patient was vaccinated with ZOSTAVAX (dose, frequency, route and Lot# unspecified). On unspecified date in October 2014 the patient experienced red rashes on waistline, jaw pain, and pain all over body after taking ZOSTAVAX. She also stated that she had a case of shingles prior to vaccination as well and stated that this was a case of shingles as well. The patient was given ointments for rash, and medication for pain. The patient had blood work, result was not reported. The patient also had her teeth treated. The patient had sought medical attention. The outcome of shingles was unknown. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (BNT162B2), on 24Dec2020 as dose 1, single (Lot number: EL1040), in left arm, on 14Jan2021 as dose 2, single (Lot number: EL1283), in left arm, on 25Sep2021 as dose 3 (booster), single (Lot number: FF8839), in left arm and on 31Mar2022 as dose 4 (booster), single (Lot number: FK9895) at the age of 54 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing), notes: Other medical history: Depression. Concomitant medication(s) included: WELLBUTRIN; ATORVASTATIN; VITAMIN D NOS. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Indication=Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient received other medications i.e., Wellbutrin, Atorvastatin Vitamin D, in two weeks of vaccination. Patient had received Paxlovid for adverse event treatment (Treatment start date was 10Jun2022 & Treatment stop date was 14Jun2022). Patient had no known allergies reported.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events Vaccination failure and Covid-19 and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Started with severe diarrhea on 1.26.2021 and am still currently experiencing this.
Patient presented to the pharmacy with a red rash around and below shingrix injection site. It was warm to the touch. Patient stated she first noticed this rash 9/22/23. She denied any other symptoms other than red appearance and hot to the touch. Denied fever, pain, itching or any other symptoms.
mother got a few shot about 15 years ago and got deathly ill; Initial information received on 12-Feb-2022 regarding an unsolicited valid Social Media non-serious case received from a patient.  This case involves an elderly female patient who got a few shot about 15 years ago and got deathly ill while receiving Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date about 15 years ago, the patient received a dose of suspect Influenza vaccine (dose, route, strength, frequency, form, batch number: unknown) for immunization.  On an unknown date, the patient got a few shot about 15 years ago and got deathly ill (critical illness) (unknown latency) following the administration of Influenza vaccine. The event has been assessed as medically significant.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (critical illness).  At time of reporting, the outcome was Unknown for the event (critical illness).; Sender's Comments: Sanofi Company Comment dated 18-Feb-2022: This case involves an elderly female patient who had experienced "my mother got a few shot about 15 years ago and got deathly ill" (critical illness) while being treated with Influenza vaccine. Based on the limited information provided regarding this case, causal role of the company suspect product cannot be excluded. However, lack of information of past, medical, family history and concomitant medication precludes comprehensive case assessment. Based upon the reported information, the role of the individual suspect vaccine cannot be assessed.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 01-AUG-2014, the patient was vaccinated with a dose of ZOSTAVAX (dose number was not reported), 0.65 ml, subcutaneous. Co-suspect and concomitant therapies were not reported. The pharmacist reports that on 01-AUG-2014, dose of ZOSTAVAX that underwent a temperature excursion was administered to five patients. (MARRS 1408USA006490, 1408USA006491, 1408USA006492 and 1408USA001809). This case is one (1) of five (5) reports from the same source. Additional information has been requested.
Woke up at 4 am on 01/31/2021 with muffled hearing and numbness on left side of body. BP increased to 150/100. Vomiting and diarrhea. Went to ER on 02/01/2021 and had MRI of the brain to check for stroke/TIA. Had an EKG and carotid artery scan. All tests came back normal. Continued to have neuropathy only on the left side of the body since 01/31/21. Pain travels from nerve to nerve. Occasional HA with pain only on the left side of the head. Cold tightness in chest. Seen PCP numerous times and had bloodwork done, Symptoms have continued since onset on 01/31/21 with no increase or decrease in severity. PCP has referred him to a neurologist.
Patient developed wheezing and stuffy nose about 2 hours after the TD and high dose Flu shot. She states it is not unusual to have stuffy nose and wheezing for her after the flu shot. This was her first dose of the high dose flu shot, previously received regular flu shot. 9/25 pm, when went to lay down for bed, pulse felt like it was racing, like had a cup of coffee. She checked pulse and it was 88. Denies any palpitations. She was up and feeling wide awake until about 3 am. All day Saturday, she felt feverish, chilled, body aches, no energy. She took Tylenol every 4 hours or so. Went to bed and woke up feeling better by Sunday. Symptoms fully resolved and did not reoccur within 48 hours of the 2 vaccines.
Patient returned to our pharmacy 3 days and 3 hours after receiving Prevnar immunization with swollen arm.  Her left arm was visibly swollen and enlarged.  We encouraged patient to follow up with her primary care provider or local instacare for treatment.  The patient did state that she was experiencing discomfort and wanted to inform our pharmacy.
More than 75 warts on my daughter's left leg - between the knee and ankle.  We did not think of this as an adverse reaction at the time but May/June 2011 she went to a dermatologist to have the warts removed by laser.  It did not work and she now has about 50 more warts on the same leg in the same area.  She has has a total of 3 Gardasil shots but looking back the warts started after the first shot on 8/23/2007.
pt recvd & less than 48 hrs later pt presented w/tinnitus in lt ear; audiologic exam revealed mod to severe sensorineural hearing loss between 1.5 & 4 KHz in lt ear; tympanogram rslts indicated complete reflex decay; viral infect poss caus
This spontaneous case reported by a consumer, describes the occurrence of chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026B21A) for COVID-19 immunization. No medical history reported. On Apr 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced  chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever). At the time of the report,  chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever) outcome: unknown. Diagnostic results: On an unknown date, body temperature:  Low-grade fever (low). No concomitant medication or treatment information reported. Patient took second dose on May 27, 2021. Action taken with mRNA-1273 in response to the events: not applicable. This case linked to MOD-2021-186718 (patient link).
Dose number=3; Flu-like symptoms; This is a spontaneous report from a contactable reporter (consumer or other non-HCP).   A 56-year-old male patient received bnt162b2 (BNT162B2), administration date an unknown date in Dec2021 (Lot number: unknown) at the age of 56 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN, Route of Administration: Unspecified), for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: UNKNOWN, Route of Administration: Unspecified), for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset an unknown date in Dec2021, outcome "unknown", described as "Dose number=3"; INFLUENZA LIKE ILLNESS (non-serious) with onset an unknown date in Dec2021, outcome "unknown", described as "Flu-like symptoms". Therapeutic measures were not taken as a result of influenza like illness.  Additional information: It was unknown if the patient received any other vaccines within four weeks the prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine administered 3 months ago, developed a steril abscess to right thigh - 2x2 cm.  Red and firm center.  Well lowlated.  Non-tender.
Itching on shoulder and neck during first 15 minutes after Janssen COVID vaccine administration. Observed for additional 20 minutes by EMS. No treatment provided.
Patient immediately had severe swelling, redness, and heat 2 hours after injection. She says she had injection site reactions before but this was much worse than she's ever experienced. The swelling was treated with ibuprofen and ice around the clock for 48 hours before it resolved. She states that the vaccine was given a little more laterally than the usual deltoid area .
Want the temperature to go down; Sore arm/arm pain; Swelling/arm swelled; Pain in shoulder; This spontaneous case was reported by a patient and describes the occurrence of FEELING HOT (Want the temperature to go down), VACCINATION SITE PAIN (Sore arm/arm pain), VACCINATION SITE SWELLING (Swelling/arm swelled) and ARTHRALGIA (Pain in shoulder) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced FEELING HOT (Want the temperature to go down), VACCINATION SITE PAIN (Sore arm/arm pain), VACCINATION SITE SWELLING (Swelling/arm swelled) and ARTHRALGIA (Pain in shoulder). The patient was treated with ETHANOL (LINIMENT AQUOS SR) for Adverse event, at an unspecified dose and frequency and ISOPROPANOL (RUBBING ALCOHOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING HOT (Want the temperature to go down), VACCINATION SITE PAIN (Sore arm/arm pain), VACCINATION SITE SWELLING (Swelling/arm swelled) and ARTHRALGIA (Pain in shoulder) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.     Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Patient states she doesn't need anymore follow up.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I intially had no adverse reactions to the vaccine on 2/14/2021. I woke up at 4:30am pm the 15th with a fever. I was fatigued and feverish all day. My temperature rose to 101.9 at the highest point on the evening of the 15th. When I awoke on the 16th, I had a low grade fever of 99.9 and was fatigued, but by early afternoon. I felt normal.  Please not. that I was ill last March when covid tests were not available in my state. I have had a positive antibody to test showing that I have had Covid-19.
pt recv vax FEB96 & 2 days later pt exp a low grade fever & was irritable;fever rose to 101.6 & refused to eat solid foods;mom also reported that pt had been very sleepy;
collarbone pain; hair loss; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 79 year-old female patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Lot number: EM9809) at the age of 79 years as dose 2, single for COVID-19 immunization. Relevant medical history included: "autoimmune disease" (unspecified if ongoing). Concomitant medication(s) included: URSODIOL. Vaccination history included: Bnt162b2 (Batch/Lot number: EL9262), administration date: 03Feb2021, for Covid-19 Immunization.  The following information was reported: PAIN (non-serious), outcome "Not recovered", described as "collarbone pain"; ALOPECIA (non-serious), outcome "Not recovered", described as "hair loss". Therapeutic measures were not taken as a result of pain, alopecia.  Additional Information: Consumer stated, she just want to report possible side effects, she got post her shot. start date of experiencing the problems, consumer stated, She had two problems one was the pain in the collar bone and the other was hair loss, her hair was coming out. Consumer further added, she got her First shot on February 3, she was just giving you the estimate, she was not a 100% sure. She would say in the middle of February, She was not sure 100%. When probed for the doctor details, consumer stated, she will you her regular doctor. When probed for the facility details, consumer stated, "The vaccine was administered at (Address). When probed for the number of facility, consumer stated, she had no idea. When probed for the expiration date, consumer stated, "she don't have an expiration date. When probed for the NDC, consumer stated, "she don't see a bar code. When probed for the dose, consumer stated, she don't have either. When probed for route of administration, consumer stated, she don't have anything other than what she gave u. Concomitant medications: Consumer stated, yes, but she was on all those medications from last 1 year. When probed if the event was worsened, improved or persisting, consumer stated, She still have it. Consumer stated, She just want to know how long it is going to last. Consumer was provided with the number of Pfizer Medical Information.  Follow-up attempts are completed. No further information is expected.
she has been having a headache since Sunday; This is a spontaneous report received from a contactable consumer (patient). This female patient of unspecified age received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on Saturday (13Mar2021) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a headache since Sunday (14Mar2021). The patient wanted to know if she could take acetaminophen (TYLENOL) or ibuprofen (ADVIL) to treat it. The outcome of headache since Sunday was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
pt recvd vax; lab tests evaluated an elevated SGOT 152 IU/L;
Wife called 9/27/11 to report that he had a fever (101.4) in AM, legs aching on 9/25/11. Referred to MD. 12/2/11 I called to follow up, wife did not remember this episode, husband is fine.
Same night as shot: right arm soreness lasting 24 hours 2 Days after shot: really bad diarrhea lasting 12 hours Both cleared up on their own
Information has been received from a registered nurse for VARIVAX (Merck), a Pregnancy Registry product, concerning a 32 year old female patient who on an unspecified date, was vaccinated with a dose of VARIVAX (Merck) (lot #, dose and route not reported). Secondary suspect therapy on an unspecified date, included MMR II (lot #, dose and route not reported). The registered nurse reported that on an unspecified date, the patient found out she was pregnant after receiving VARIVAX (Merck) and MMR II. At the time of the report, the patient's last menstrual period and the estimated delivery date were unknown. No adverse effect known. Follow up information has been received from the registered nurse who reported that the patient had an elective abortion in December 2011. The registered nurse was not sure of the gestational date at termination. She also reported that there was no knowledge of any congenital anomalies in the fetus, but reported that the patient wanted to terminate the pregnancy despite reassurances of positive fetal health outcomes. Upon internal review elective abortion was considered to be a medical significant event. Additional information is not expected.
Patient may have received ProQuad that was not stored at the recommended temperature.  No reaction or adverse event
36 hours of intense pain all over , fever , rigors, visible swelling of joints , swollen lymph node in armpit of left arm
Difficulty breathing, elevated heart rate, high fever (103.5), weakness, lethargy. Difficulty breathing and heart rate returned to normal after fever was under control 11:30 PM. Fever is still over 103 when either TYLENOL or MOTRIN wears off (we are alternating every 3 hours, but not waking to administer). It has now been almost 48 hours. Child is still lethargic and fussy. Child has never had a fever prior to this, even with bronchiolitis at 2 months old.
Headache, joint pain, malaise and fatigue, decreased appetite. Started within 12 hours of vaccine administered, lasted 24 hours.
Rash developed after taking Famotidine.  After researching, I discovered that it is labeled COVID toes.  If it does not subside I will seek treatment.
Body aches; Swollen lymph node on the left side, back of the tongue leading to her ear canal; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 77; unspecified unit) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 28Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the second dose of the COVID-19 vaccine on 28Jan2021, in which she experienced body aches and a swollen lymph node on the left side, back of the tongue leading to her ear canal. The patient was self-treating with cefalexin (KEFLEX) and ibuprofen, in which she has noticed that her symptoms are becoming lesser. The patient has a physical examination scheduled next week. The patient asked how long this is going to last and what should she do about it. The patient compared her symptoms with a laboratory technician who experienced swollen lymph nodes. The patient was recovering from the events.  Follow-up attempts are completed. No further information is expected.
Red rash with red line around and swelling with itching appeared 9 days after injection...got larger and darker red after it first appeared....started easing in severeness on day 14...still slightly apperaring at time of this report
Mild to moderate hives without involvement of oral mucosa or respiratory sx. Non-systemic; follows joints. Hives appeared first to left elbow, followed by knees, ankles, wrist, and finger joints bilaterally. Onset approximately within 4 hours of injection. Resolving by following day. Patient self-administered OTC BENADRYL evening of 3/20/18.  Patient with no hx of vaccine reactions in the past-- she has received all routine childhood vaccines.